A finger-powered microfluidic device was developed for personalized drug testing with patient-derived organoids. The low-equipment platform integrates sample handling and treatment assessment in a compact workflow, aiming to make organoid-based response testing more accessible while preserving information needed for individualized therapeutic evaluation.
Countstar Connection
The Countstar Mira FL Pro assessed viability, cell number, and clumping in dissociated organoid samples before their use in microfluidic personalized drug-testing experiments.
